Toggle light / dark theme

A heat sensor for living cells could offer new views of cell metabolism, rapid antibiotic testing

When living cells grow, divide or respond to drugs, they give off tiny amounts of heat that offer information about what the cells are doing. But because these heat signals are so vanishingly small, they have traditionally been impossible to measure directly. Researchers in the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) have developed a calorimeter—a device that measures the heat transfer between a living system and its environment—that can detect metabolic heat signals on the order of 100 picowatts, or trillionths of a watt, in living cells.

The device is the most sensitive of any comparable bio-calorimeter to date. The new “pico-calorimeter” can track the metabolism of small populations of bacteria in real time, as well as monitor how bacterial growth changes in response to different antibiotics.

The work is from the lab of Joost Vlassak, the Abbott and James Lawrence Professor of Materials Engineering, and was carried out by Harvard associate Juanjuan Zheng, a former postdoctoral researcher in Vlassak’s lab. The research is published in the Proceedings of the National Academy of Sciences.

Nanomedicine discovery uses salt to overcome major obstacle in gene therapy

Researchers at the University of Houston’s College of Pharmacy have discovered an unexpectedly simple strategy to improve the performance of mRNA vaccines and gene therapeutics: adding salt. The findings, published in Small, address one of the biggest challenges facing modern gene medicine—getting fragile therapeutic material to the right place inside cells.

“We are introducing salt-loaded lipid nanoparticles as a novel and broadly applicable design principle for gene delivery,” said Fanfei Meng, assistant professor and Presidential Frontier Faculty member in the Department of Pharmacological and Pharmaceutical Sciences. “What makes this exciting is that we can significantly improve delivery efficiency without needing to invent entirely new materials.”

Lipid nanoparticles, or LNPs, are tiny fat-based delivery vehicles widely used to transport fragile genetic material into cells. They became widely recognized during the COVID-19 pandemic through mRNA vaccines developed by Moderna and Pfizer. Today, scientists are also using LNPs to develop new treatments for cancer, rare diseases and genetic disorders.

Debate on human aging and lifespan

The issue of human lifespan has long been a matter of controversy among scientists. In spite of the recent claim by Dong et al that human lifespan is limited to 115 years, with the mounting improvements in biotechnology and scientific understanding of aging, we may be confident that aging will slow down over the course of the current century extending human longevity much longer than 115 years.

Mapping immune cell interactions in gut tissue reveals changes in ulcerative colitis

In a new study published in Science Immunology, researchers at King’s College London looked at a type of tissue important for the immune response called gut-associated lymphoid tissue (GALT), which is located within the lining of the gut. Unlike other tissue structures in the gut lining that act as a barrier between the trillions of bacteria in the gut and the rest of the body, GALT actively transports gut microbes into the body. By doing this, GALT activates immune responses that help maintain a stable relationship with beneficial gut bacteria.

Typically, when the body encounters microbes, it triggers inflammation, sending immune cells to the affected area to fight the pathogen. However, GALT behaves differently. Despite its close and consistent interaction with microbes, GALT does not become inflamed.

To understand how GALT achieves this, the team mapped the interactions and locations of immune cells in GALT. They also looked at how these interactions changed in ulcerative colitis—an inflammatory bowel disease in which parts of the large bowel become swollen, inflamed and ulcerated. According to Crohn’s & Colitis UK, at least 1 in every 233 people in the U.K. have ulcerative colitis. The condition can significantly affect quality of life. Previous research has linked GALT in the appendix to ulcerative colitis.

Many cancers originate from a single cancer cell and evolve through early bursts of chromosome changes

A comprehensive multi-cancer study by researchers at The University of Texas MD Anderson Cancer Center has revealed that cancer cells within tumors are genetically diverse, yet all carry the same core genetic changes that can be traced back to a common ancestral cell, providing a single-cell view of how tumors adapt, survive and diversify. Understanding this helps explain why some cancer cells manage to survive treatment, paving the way for more tailored diagnostic and therapeutic strategies.

The study, published in Cancer Discovery, was led by Nicholas Navin, Ph.D., chair of Systems Biology. The research shows that cancer cells do not evolve slowly over time, but rather grow through sudden bursts of rapid genetic changes that include copy number alterations (CNAs)—gains or losses of entire sections of DNA. This creates a family tree of distinct new subpopulations that can influence tumor aggressiveness, metastasis and treatment response.

“Our findings provide the clearest views to date of how cancers originate and evolve at the single-cell level,” Navin said. “By revealing both the shared early genetic events and the bursts that drive ongoing diversity, we now have a roadmap for developing smarter clinical diagnostic and treatment strategies to improve patient outcomes.”

Dell CEO Michael Dell makes one of largest public university donations in US history, ‘gifts’ $750 million to the University of …

Dell CEO Michael Dell has donated $750 million to the University of Texas at Austin, marking one of the largest donations ever made to a public university in the United States. The gift will help fund a new healthcare and research campus, including what the university describes as the country’s first artificial intelligence-native hospital.

The Future of Neuroscience Is Growing and Reviving Human Brains

Further Reading.
Thumbnail image credit: Not alive, but not dead… FEATURED SCIENCE ARTICLE.
Brain background: Nexorg.
Brain organoid images: Elke Gabriel.

Not alive, but not dead: disembodied human brains used for drug testing.
https://www.science.org/content/artic
Restoration of brain circulation and cellular functions hours.
https://pubmed.ncbi.nlm.nih.gov/30996

Vascularizing organoids-on-chip for perfused and personalized models.
https://pubs.rsc.org/en/content/artic

Startup Testing Drugs on Freshly Extracted Human Brains That Are Kept On Life Support.
https://futurism.com/health-medicine/.

Cerebral organoids transplantation repairs infarcted cortex and restores impaired function after stroke https://www.nature.com/articles/s4153

World First: Patient Receives High-Risk Therapy to Make Cells Young Again

An eagerly awaited and controversial clinical trial to ‘wind back the clock’ on aging cells in the eye and restore them to a more youthful state has officially begun.

This week, the United States biotechnology company Life Biosciences, Inc. announced that it had dosed its first patient with an experimental therapy designed to reverse age-related vision loss.

The ambitious idea is to turn back aging by activating three genes in retinal ganglion cells, which connect the brain to the eyes.

/* */